Yes, it's clear for GBM that DCVax will replace SOC with the cure rate being improved further with adjuvants or neoadjuvants given in combination with DCVax.
Looks like it to me, and yes, with the adjuvants that seem to further increase response and improve outcomes. So it could and should be very successful IMHO.